These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33470082)

  • 1. Factors associated with unfavourable treatment outcomes in people with HIV-associated tuberculosis in Armenia, 2015 to 2019.
    Gevorgyan L; Grigoryan R; Dumchev K; Akopyan K; Khachatryan A; Kabasakalyan E; Grigoryan T; Safaryan M; Avagyan V; Hasanova S; Matteelli A
    Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with unfavourable treatment outcomes among people with rifampicin-resistant tuberculosis in Armenia, 2014-2017.
    Khachatryan L; Grigoryan R; Dadu A; Kumar AMV; Akopyan K; Dumchev K; Harutyunyan H; Matteelli A
    Monaldi Arch Chest Dis; 2021 Jan; 91(1):. PubMed ID: 33470086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries.
    Pettit AC; Jenkins CA; Blevins Peratikos M; Yotebieng M; Diero L; Do CD; Ross J; Veloso VG; Hawerlander D; Marcy O; Shepherd BE; Fenner L; Sterling TR;
    J Int AIDS Soc; 2019 Dec; 22(12):e25423. PubMed ID: 31814312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gaps in tuberculosis control in Armenia: How to improve the care system?
    Davtyan H; Petrosyan A; Aslanyan G; Aghabekyan S; De Basso D; Davtyan K
    J Infect Dev Ctries; 2020 Nov; 14(11.1):133S-139S. PubMed ID: 33226972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
    Nglazi MD; Bekker LG; Wood R; Kaplan R
    BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and treatment outcomes of recurrent tuberculosis in Tanzania from 2018 to 2021 using the National TB dataset.
    Njiro BJ; Kisonga R; Joachim C; Sililo GA; Nkiligi E; Ibisomi L; Chirwa T; Francis JM
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011968. PubMed ID: 38359088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
    Assefa A; Gelaw B; Getnet G; Yitayew G
    BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data.
    Nanzaluka FH; Chibuye S; Kasapo CC; Langa N; Nyimbili S; Moonga G; Kapata N; Kumar R; Chongwe G
    Pan Afr Med J; 2019; 32():159. PubMed ID: 31308862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of isoniazid preventive therapy on tuberculosis incidence and associated risk factors among HIV infected adults in Tanzania: a retrospective cohort study.
    Sabasaba A; Mwambi H; Somi G; Ramadhani A; Mahande MJ
    BMC Infect Dis; 2019 Jan; 19(1):62. PubMed ID: 30654753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A five-year audit of gaps in HIV testing and associations with TB treatment outcomes in Armenia, 2015-2019.
    Abrahamyan A; Hann K; Akopian K; Grigoryan R; Petrosyan O; Davtyan H
    J Infect Dev Ctries; 2021 Sep; 15(9.1):43S-50S. PubMed ID: 34609959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to tuberculosis development and its predictors among HIV-positive patients: A retrospective cohort study.
    Ajema AT; Simachew Y; Meshesha MD; Gari T
    PLoS One; 2024; 19(2):e0298021. PubMed ID: 38346004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patching the gaps towards the 90-90-90 targets: outcomes of Nigerian children receiving antiretroviral treatment who are co-infected with tuberculosis.
    Chamla DD; Asadu C; Davies A; de Wagt A; Ilesanmi O; Adeyinka D; Adejuyigbe E
    J Int AIDS Soc; 2015; 18(Suppl 6):20251. PubMed ID: 26639112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?
    Anígilájé EA; Aderibigbe SA; Adeoti AO; Nweke NO
    PLoS One; 2016; 11(5):e0156177. PubMed ID: 27232185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.
    Podlekareva DN; Efsen AM; Schultze A; Post FA; Skrahina AM; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J; Miro JM; Vassilenko A; Girardi E; Bruyand M; Obel N; Lundgren JD; Mocroft A; Kirk O;
    Lancet HIV; 2016 Mar; 3(3):e120-31. PubMed ID: 26939735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
    Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
    PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study.
    Sinha S; Gupta K; Tripathy S; Dhooria S; Ranjan S; Pandey RM
    BMC Infect Dis; 2017 Dec; 17(1):761. PubMed ID: 29228918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015-2017 Cohort from Tashkent, Uzbekistan.
    Sadirova D; Grigoryan R; Parpieva N; Barotova V; Trubnikov A; Kalandarova L; Gadoev J; Mukhtarov D; Buziashvili M; Tukvadze N; Hovhannesyan A; Dadu A
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34071899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.